Identification of a subpopulation of metastatic breast cancer patients with very high HER2 expression levels and possible resistance to trastuzumab-Reference-Cited by-同舟云学术

Identification of a subpopulation of metastatic breast cancer patients with very high HER2 expression levels and possible resistance to trastuzumab

Published:2011-09 Issue:9 Volume:22 Page:2014-2020
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bates M.,Sperinde J.,Köstler W.J.,Ali S.M.,Leitzel K.,Fuchs E.M.,Paquet A.,Lie Y.,Sherwood T.,Horvat R.,Singer C.F.,Winslow J.,Weidler J.M.,Huang W.,Lipton A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/22/9/2014/13784793/mdq706.pdf

Reference31 articles.

1. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease;Cobleigh;J Clin Oncol,1999

2. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer;Vogel;J Clin Oncol,2002

3. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

4. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer;Romond;N Engl J Med,2005

5. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer;Piccart-Gebhart;N Engl J Med,2005

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer;Breast Cancer Research;2024-02-07

2. A Review and Meta-analysis on Trastuzumab Resistance in Patients with HER2+ Breast Cancer;Mini-Reviews in Medicinal Chemistry;2023-06

3. Recapitulating the Lateral Organization of Membrane Receptors at the Nanoscale;ACS Nano;2023-05-18

4. Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer;The Breast;2022-12

5. The emerging role of radionuclide molecular imaging of HER2 expression in breast cancer;Seminars in Cancer Biology;2021-07